FFCP PHASE1:Mm9::chr17:48322531..48322538,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
(2 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{{FFCP | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=NA | |EntrezGene=NA | ||
|HGNC= | |HGNC= | ||
|MCL_coexpression_id=6 | |MCL_coexpression_id=6 | ||
|TSSclassifier=NA | |||
|UniProt=NA | |UniProt=NA | ||
|association_with_transcript=NA | |association_with_transcript=NA | ||
|cluster_id=chr17:48322531..48322538,+ | |||
|description=CAGE_peak_at_chr17:48322531..48322538,+ | |description=CAGE_peak_at_chr17:48322531..48322538,+ | ||
|id=chr17:48322531..48322538,+ | |id=chr17:48322531..48322538,+ | ||
|ontology_enrichment_celltype=CL:0000355!2.64e-15!9 | |ontology_enrichment_celltype=CL:0000355!2.64e-15!9 | ||
|ontology_enrichment_celltype_v019_2=CL:0000355,3.94e-18,9 | |||
|ontology_enrichment_disease=DOID:0060100!4.58e-44!3;DOID:4045!4.58e-44!3;DOID:0050686!1.60e-22!6 | |ontology_enrichment_disease=DOID:0060100!4.58e-44!3;DOID:4045!4.58e-44!3;DOID:0050686!1.60e-22!6 | ||
|ontology_enrichment_disease_v019_2=DOID:0060100,2.47e-52,3;DOID:4045,2.47e-52,3;DOID:0050686,1.04e-26,6 | |||
|ontology_enrichment_uberon=UBERON:0001134!2.64e-15!9;UBERON:0002036!2.64e-15!9;UBERON:0002385!2.64e-15!9;UBERON:0000486!2.64e-15!9;UBERON:0001015!2.64e-15!9;UBERON:0004290!2.64e-15!9;UBERON:0003082!2.64e-15!9;UBERON:0000383!7.43e-14!10;UBERON:0002329!1.14e-12!11;UBERON:0003077!1.14e-12!11;UBERON:0003059!1.14e-12!11;UBERON:0007282!1.14e-12!11;UBERON:0009618!1.14e-12!11;UBERON:0007285!1.14e-12!11;UBERON:0000914!1.87e-08!17 | |ontology_enrichment_uberon=UBERON:0001134!2.64e-15!9;UBERON:0002036!2.64e-15!9;UBERON:0002385!2.64e-15!9;UBERON:0000486!2.64e-15!9;UBERON:0001015!2.64e-15!9;UBERON:0004290!2.64e-15!9;UBERON:0003082!2.64e-15!9;UBERON:0000383!7.43e-14!10;UBERON:0002329!1.14e-12!11;UBERON:0003077!1.14e-12!11;UBERON:0003059!1.14e-12!11;UBERON:0007282!1.14e-12!11;UBERON:0009618!1.14e-12!11;UBERON:0007285!1.14e-12!11;UBERON:0000914!1.87e-08!17 | ||
|ontology_enrichment_uberon_v019_2=UBERON:0001134,3.94e-18,9;UBERON:0002036,3.94e-18,9;UBERON:0002385,3.94e-18,9;UBERON:0000486,3.94e-18,9;UBERON:0007503,3.94e-18,9;UBERON:0001015,3.94e-18,9;UBERON:0002329,3.94e-18,9;UBERON:0003082,3.94e-18,9;UBERON:0003059,3.94e-18,9;UBERON:0007282,3.94e-18,9;UBERON:0004290,3.94e-18,9;UBERON:0009618,3.94e-18,9;UBERON:0000383,2.07e-16,10;UBERON:0007524,5.33e-15,11;UBERON:0003077,5.33e-15,11;UBERON:0007285,5.33e-15,11 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5.02237956884289,7.813353445238,1.0470474879476,27.0586484494267,4.78131839470912,0.485510353031154,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5.02237956884289,7.813353445238,1.0470474879476,27.0586484494267,4.78131839470912,0.485510353031154,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | ||
|short_description=p@chr17:48322531..48322538,+ | |short_description=p@chr17:48322531..48322538,+ | ||
}} | }} |
Latest revision as of 01:14, 5 August 2015
Short description: | p@chr17:48322531..48322538, + |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chr17:48322531..48322538, + |
Coexpression cluster: | MCL_coexpression_mm9:6 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
multi-potent skeletal muscle stem cell | 3.94e-18 | 9 |
Ontology term | p-value | n |
---|---|---|
skeletal muscle tissue | 3.94e-18 | 9 |
striated muscle tissue | 3.94e-18 | 9 |
muscle tissue | 3.94e-18 | 9 |
multilaminar epithelium | 3.94e-18 | 9 |
epithelial vesicle | 3.94e-18 | 9 |
musculature | 3.94e-18 | 9 |
somite | 3.94e-18 | 9 |
myotome | 3.94e-18 | 9 |
presomitic mesoderm | 3.94e-18 | 9 |
presumptive segmental plate | 3.94e-18 | 9 |
dermomyotome | 3.94e-18 | 9 |
trunk paraxial mesoderm | 3.94e-18 | 9 |
musculature of body | 2.07e-16 | 10 |
dense mesenchyme tissue | 5.33e-15 | 11 |
paraxial mesoderm | 5.33e-15 | 11 |
presumptive paraxial mesoderm | 5.33e-15 | 11 |
Ontology term | p-value | n |
---|---|---|
musculoskeletal system cancer | 2.47e-52 | 3 |
muscle cancer | 2.47e-52 | 3 |
organ system cancer | 1.04e-26 | 6 |